For payers, ASTRO XO™ is a cost effective exoskeleton attached to the lower leg for the treatment of multiple soft tissue and joint disorders that lead to gait deficiencies, helping to avoid or enhance extensive rehabilitation.
The Knee Component of the ASTRO XO™ is currently approved for an L1832 or L1833 code. The PDAC letter can be downloaded for use when prescribed by a Health Care Professional. Additional DME PDAC L-codes for the ASTRO XO™ device are in the process of development and approval.
It is the responsibility of the patient to secure any necessary pre-approvals for coverage. ASTRO Medical LLC makes no guarantee of reimbursement by any payer.
The following suggested ICD-10 codes relate to the ASTRO XO™ indications.
These suggested codes are provided for convenience. The final and sole responsibility for the correct coding, within established laws, rules, and standards of practice, rests solely upon the party submitting the claim.
Clinical Study Documents
The ASTRO XO™ clinical trial directly defined its efficacy for treatment of plantar fasciitis. Data collected as part of the trial also defined the ASTRO XO™ mechanism of action. These data support application of the product in a range of indications where restoration of ankle power and forward propulsion are thought to offer clinical benefit to the patient. Application of the device in all cases is at the discretion of the clinician.